Evaluating the Impact of OOLD on Access to Oral Oncology Therapies
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
How oral oncology therapies are distributed can directly impact whether patients start treatment—and how connected care remains along the way.
In this session, Chris Lehmer, PharmD, MBA (City of Hope), walks through findings from a real-world analysis comparing distribution models for oral oncology therapies.
We’ll look at how differences in distribution affect capture rate, fill rate, time to therapy, and patient retention and what those differences reveal about access, coordination, and continuity of care within a medically integrated pharmacy model.
What you’ll learn
- How distribution models influence whether prescriptions stay within the care team
- Where differences in fill rate, time to therapy, and retention begin to show up
- How to use these metrics to evaluate and improve your own workflows
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
Additional Upcoming Webinars
Upcoming Webinar
Evaluating the Impact of OOLD on Access to Oral Oncology Therapies
May 11, 2026 | 2:00 PM
